Results 181 to 190 of about 379,925 (396)

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

The Lancet, 2014
M. Brose, C. Nutting, B. Jarzab, R. Elisei, S. Siena, L. Bastholt, C. Fouchardière, F. Pacini, R. Paschke, Y. Shong, S. Sherman, J. Smit, J. Chung, C. Kappeler, C. Peña, I. Molnár, M. Schlumberger   +16 more
semanticscholar   +1 more source

Is less always more in a national well-differentiated thyroid cancer population? [PDF]

, 2019
Madelon J. H. Metman, Ivona Lončar, Schelto Kruijff, Anton F. Engelsman, Tessa M. van Ginhoven   +4 more
openalex   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

Prevalence and treatment outcomes of second primary malignancies in Saudi patients with differentiated thyroid cancers [PDF]

, 2015
Khalid Al‐Qahtani, Mushabbab AlAsiri, Mutahir A. Tunio, Naji J. Aljohani, Yasser Bayoumi, Hussain AlHussain, Ahmed Maklad   +6 more
openalex   +1 more source

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T. Muanda   +2 more
wiley   +1 more source

Outcomes of Favorable-Stage, Well-Differentiated Thyroid Cancer with Microscopic Positive Margin [PDF]

, 2017
Catherine E. Mercado, Christopher G. Morris, Robert J. Amdur   +2 more
openalex   +1 more source

Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor–Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial

, 2017
Maria E. Cabanillas, Jonas A. de Souza, Susan M. Geyer, Lori J. Wirth, Michael E. Menefee, Stephen V. Liu, Komal Shah, James R. Wright, Manisha H. Shah   +8 more
openalex   +2 more sources

Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

Thyroid, 2006
The American, Thyroid Association, Guidelines Taskforce, David S. Cooper, Chair, Gerard M. Doherty, B. R. Haugen, R. Kloos, Stephanie L. Lee, Susan J. Mandel, Ernest L. Mazzaferri, B. Mciver, S. Sherman, R. M. Tuttle, Contents, Genzyme Corp   +15 more
semanticscholar   +1 more source

Data from Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression

, 2023
Xiao-Min Yu, Renata Jaskula‐Sztul, Maria R. Georgen, Zviadi Aburjania, Yash R. Somnay, Glen Leverson, Rebecca S. Sippel, Ricardo V. Lloyd, Brian P. Johnson, Herbert Chen   +9 more
openalex   +1 more source

Cold atmospheric plasma‐mediated tumor microenvironment remodeling for cancer treatment

BMEMat, EarlyView.
Schematic presentation of CAP‐mediated TME remodeling. This review summarizes recent efforts in cold atmospheric plasma (CAP) application in cancer treatment, highlighting the anticancer potential of CAP, molecular mechanisms, and future perspectives for further improvement and clinical translation.
Israr Khan, Qiujie Fang, Cao Fei, Ziyuan Wang, Zhaowei Chen, Guojun Chen, Zhiming Xu, Shu Xu, Zhitong Chen   +8 more
wiley   +1 more source